Showing results (361-370 of 379) with videos related to

Sort By:
Pageof 38
Vaccine|September 8, 2021
Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian statesJ Sisnowski, C Vujovich-Dunn, H Gidding, et al.
BMC Public Health|April 26, 2022
Measuring school level attributable risk to support school-based HPV vaccination programsC Vujovich-Dunn, H Wand, J M L Brotherton, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer PatientsJustin D Anderson, Todd A DeWees, Daniel J Ma, et al.
International Journal of Particle Therapy|October 23, 2020
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck CancersJaden D Evans, Riley H Harper, Molly Petersen, et al.
Blood Advances|July 19, 2024
Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapyOmran Saifi, William G Breen, Scott C Lester, et al.
Blood Advances|January 11, 2024
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapyJessica F Burlile, Kelsey M Frechette, William G Breen, et al.
Archives of Dermatological Research|April 19, 2025
Rethinking the use of population descriptors in dermatology trials and beyond: disentangling race and ethnicity from skin colorValerie M Harvey, Jenna C Lester, Tarannum Jaleel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 10, 2021
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?Omran Saifi, William G Breen, Scott C Lester, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical TrialDavid M Routman, Kathryn M Van Abel, Katharine A Price, et al.
Oral Oncology|January 5, 2023
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)T J Haller, X L Yin, T J O'Byrne, et al.
Pageof 38